Evidence map›Paper›PMID 25915643›Full record

ArticlePloS one2015

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia.

Kriangsuk Srijaruskul, Nisanart Charoenlap, Poommaree Namchaiw, Sorayut Chattrakarn, Suparat Giengkam, Skorn Mongkolsuk, Paiboon Vattanaviboon

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Mutation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Frontiers in microbiology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antimicrobial Resistance inMicrobiology spectrum · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kriangsuk SrijaruskulLaboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, 10210, Thailand; Program in Applied Biological Sciences: Environmental Health, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
Nisanart CharoenlapLaboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
Poommaree NamchaiwLaboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
Sorayut ChattrakarnProgram in Applied Biological Sciences: Environmental Health, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
Suparat GiengkamProgram in Applied Biological Sciences: Environmental Health, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
Skorn MongkolsukLaboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, 10210, Thailand; Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand; Center of Emerging Bacterial Infection, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand; Center of Excellence on Environmental Health and Toxicology, Bangkok, Thailand.
Paiboon VattanaviboonLaboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, 10210, Thailand; Program in Applied Biological Sciences: Environmental Health, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
Chulabhorn Graduate Institute · THChulabhorn Research Institute · THMahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stenotrophomonas maltophilia MfsA (Smlt1083) is an efflux pump in the major facilitator superfamily (MFS). Deletion of mfsA renders the strain more susceptible to paraquat, but no alteration in the susceptibility levels of other oxidants is observed. The expression of mfsA is inducible upon challenge with redox cycling/superoxide-generating drug (paraquat, menadione and plumbagin) treatments and is directly regulated by SoxR, which is a transcription regulator and sensor of superoxide-generating agents. Analysis of mfsA expression patterns in wild-type and a soxR mutant suggests that oxidized SoxR functions as a transcription activator of the gene. soxR (smlt1084) is located in a head-to-head fashion with mfsA, and these genes share the -10 motif of their promoter sequences. Purified SoxR specifically binds to the putative mfsA promoter motifs that contain a region that is highly homologous to the consensus SoxR binding site, and mutation of the SoxR binding site abolishes binding of purified SoxR protein. The SoxR box is located between the putative -35 and -10 promoter motifs of mfsA; and this position is typical for a promoter in which SoxR acts as a transcriptional activator. At the soxR promoter, the SoxR binding site covers the transcription start site of the soxR transcript; thus, binding of SoxR auto-represses its own transcription. Taken together, our results reveal for the first time that mfsA is a novel member of the SoxR regulon and that SoxR binds and directly regulates its expression.

Indexed as

Drug Resistance, MicrobialGene Expression Regulation, BacterialAmino Acid SequenceAnti-Bacterial AgentsBacterial ProteinsBase SequenceMembrane Transport ProteinsMolecular Sequence DataParaquatPromoter Regions, GeneticProtein BindingStenotrophomonas maltophiliaTranscriptional ActivationTranscription FactorsAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsParaquatSoxR protein, BacteriaTranscription Factors

Identifiers

PMID25915643
PMCPMC4411124
OpenAlexW1979922836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.